Skip to main content
Clinical Trials/NCT04030312
NCT04030312CompletedNot Applicable

Effectiveness of Donor Human Milk Supplementation Compared to Infant Formula for the Treatment of Hypoglycemia in the Breastfed Infant in the Normal Newborn Nursery

University of Nebraska1 site in 1 country18 target enrollmentStarted: May 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
18
Locations
1
Primary Endpoint
Effectiveness of Resolving Neonatal Hypoglycemia: Blood glucose levels

Study Overview

Brief Summary

The purpose of this study is to compare if newborn infant hypoglycemia can be improved with bottle supplementation of commercially-sterilized donor human milk compared to standard infant formula. Hypothesis is that supplementation with commercially-sterilized donor human milk will improve hypoglycemia and limit formula use in exclusively breastfed infants.

Detailed Description

Enrolled infant participants will receive a maximum of two bottle feeding supplementations (of their designated treatment arm for either 20 calorie-per-ounce commercially-sterilized donor human milk OR 20-calorie-per-ounce standard infant formula) as treatment if they meet hypoglycemia criteria. Infant participants will complete the study if 1) they have received two bottle feeding supplementations for treatment of hypoglycemia, 2) they only received one bottle supplementation and hypoglycemia resolved, 3) if the medical teams deems the infants requires a higher level of care for their hypoglycemia (example: admission to the newborn intensive care unit for intravenous fluids with dextrose).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
1 Minute to 72 Hours (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Mother-infant pairs will be consented for participation via informed written consent.
  • •Inclusion Criteria:
  • •Mother/infant dyads deliverying at Nebraska Medicine hospital (Omaha, NE, USA).
  • •Infant in the normal newborn nursery, born greater than or equal to 36 weeks gestational age.
  • •Infant with blood glucose after delivery of < 40 milligrams/deciliter within the first four hours of life OR blood glucose levels less than 45 milligrams/deciliter after four hours of life
  • •Deliverying mother plans to exclusively breastfeed.

Exclusion Criteria

  • •Infants born and directly admitted to the newborn intensive care unit
  • •Infants with known congenital abnormality or known inborn error of metabolism that influences growth and metabolic outcomes
  • •Infants deemed ward of state
  • •Mothers who do not plan to exclusively breastfeed at time of delivery
  • •Mothers less than 19 years of age

Arms & Interventions

Standard Infant Formula

Active Comparator

Infants in this randomized treatment arm will receive bottle supplementation of up to 15 milliliters of standard 20 calorie-per-ounce infant formula up to two times during the duration of the study to treat hypoglycemia.

Intervention: Bottle Supplementation--Standard Infant Formula (Dietary Supplement)

Commercially-Sterilized Donor Human Milk

Experimental

Infants in this randomized treatment arm will receive bottle supplementation of up to 15 milliliters of 20 calorie-per-ounce commercially-sterilized donor human milk up to two times during the duration of the study to treat hypoglycemia.

Intervention: Bottle Supplementation--Commercially-Sterilized Donor Human Milk (Dietary Supplement)

Outcomes

Primary Outcomes

Effectiveness of Resolving Neonatal Hypoglycemia: Blood glucose levels

Time Frame: Blood glucose levels will be monitored within 60 minutes of initiating a feeding. Overall outcomes for each treatment arm will be compared at the completion of the study for all enrolled participants.

To compare the effectiveness of commercially-sterilized donor human milk bottle supplementation for the treatment of hypoglycemia in the breastfed infant in the normal newborn nursery compared to bottle supplementation with standard infant formula.

Secondary Outcomes

  • Exclusive Breastfeeding Duration(Families of consented participants will be contacted when the enrolled infant is 6 months old.)
  • Parenteral Satisfaction of Infant Feeding: Parenteral satisfaction surveys(Parenteral satisfaction surveys will be completed prior to mother's hospital discharge (within 72 hours following delivery).)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials